The dispute over who administers these medications follows a long list complaints over health plan rules that seek to ...

The term "prior authorization" has become reviled on Capitol Hill. Yet legislation to limit health insurance pre-certifications has been held up time and again, not unlike the treatments and ...

Biotech company Sarepta Therapeutics (NASDAQ ... total product revenue lowered to $2.45 billion (from ($3.0 billion prior) while combined R&D and SG&A expense raised to $2.0 billion (from $1. ...

The state of Michigan has sued pharmacy benefit managers Express Scripts and Prime Therapeutics for anticompetitive behavior and suppression of reimbursement rates to independent pharmacies.

NEW YORK, May 05, 2025 (GLOBE NEWSWIRE) -- TG Therapeutics, Inc. (NASDAQ ... was well tolerated in individuals with RMS regardless of prior treatment or B-cell depletion status Rapid 30-minute ...

CAMBRIDGE, Mass. (AP) — CAMBRIDGE, Mass. (AP) — Seres Therapeutics Inc. (MCRB) on Wednesday reported first-quarter net income of $32.7 million. On a per-share basis, the Cambridge, Massachusetts-based ...

We feel now is a pretty good time to analyse Unicycive Therapeutics, Inc.'s (NASDAQ:UNCY) business as it appears the company may be on the cusp of a considerable accomplishment. Unicycive Therapeutics ...

Announced that effective February 1, 2025, Prime Therapeutics has added the iLet Bionic Pancreas ... Beta Bionics to bridge previous bihormonal clinical data, which tested prior formulations of ...

Shares in US biotech Five Prime Therapeutics more than tripled after it reported promising trial results with stomach cancer drug candidate bemarituzumab, returning the stock to levels not seen ...

Nearly all those who have Medicare Advantage plans must deal with prior authorization. Now more prior authorization issues are appearing with Part D prescription drugs.